Notably, RA patients frequently report improved cognition and stabilized mood following cytokine‐inhibiting therapy, likely because suppressing elevated systemic inflammatory factors like IL‐6 and TNF blocks their induction of depression and fatigue via neural pathways, thereby conferring additional benefits to the CNS [681]. This evidence concerns the gene TNF and depressive symptom measurement.